Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance
- 12:00 - 13:00
- 8/07/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Tumor Biology and Biomarkers
- Moderators:Benjamin Besse, Yuko Minami
-
+
Session Moderator
12:50 - 13:00 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
Session Moderator
12:50 - 13:00 | Presenter: Yuko Minami
- Abstract
Loading... -
+
ES07.01 - Session Introduction
12:00 - 12:01 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
ES07.02 - Session Introduction
12:01 - 12:02 | Presenter: Yuko Minami
- Abstract
Loading... -
+
ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression
12:02 - 12:14 | Presenter: Trever Bivona
- Abstract
Loading... -
+
ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)
12:14 - 12:26 | Presenter: Sandra Ortiz-Cuaran
- Abstract
Loading... -
+
ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC
12:26 - 12:38 | Presenter: Triparna Sen
- Abstract
Loading... -
+
ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics
12:38 - 12:50 | Presenter: Helmut Popper
- Abstract
Loading... -
+
ES07.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-090 - Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront.
Presenter: Teresa Gorria- Abstract
Loading... -
+
EP08.01-091 - Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone +/- Chemotherapy Upfront
Presenter: Teresa Gorria- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-016 - Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs
Presenter: Benjamin Besse- Abstract
Loading... -
+
EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study
Presenter: Alexander Drilon- Abstract
Loading... -
+
EP08.02-173 - Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings
Presenter: Joshua Sabari- Abstract
Loading...
-
+
P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
P1.16-02 - Clinical Utility of ctDNA in Advanced NSCLC at Diagnosis or Where Insufficient Tissue Was Available, Based on the ESMO ESCAT Scale
Presenter: Laura Mezquita- Abstract
Loading...
-
+
PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)
- 08:30 - 10:20
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Heather Wakelee, Eric Lim
-
+
PL03.10 - Discussant
Presenter: Benjamin Besse- Abstract
Loading...
-
+
OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
- 11:00 - 12:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Moderators:Lubos Petruzelka, Pilar Garrido
-
+
OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
11:32 - 11:42 | Presenter: Edouard Auclin
- Abstract
Loading...
-
+
MA07 - Overcoming Resistance to EGFR Inhibitors
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Dana Lucia Stanculeanu, Ross Soo
-
+
MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA
12:42 - 12:47 | Presenter: Laura Mezquita
- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Noboru Yamamoto, Paul J Van Houtte
-
+
MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)
15:17 - 15:22 | Presenter: Jose Carlos Benítez
- Abstract
Loading...
-
+
IS24 - Industry Sponsored Symposium by MSD: New Frontiers in the Management of NSCLC
- 18:00 - 19:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
IS24.03 - Emergence of Immuno-Oncology in Early-Stage Operable NSCLC
18:15 - 18:30 | Presenter: Benjamin Besse
- Abstract
Loading...
-
+
OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Epidemiology
- Moderators:Matthew T Warkentin, Hilary A Robbins
-
+
OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study
10:57 - 11:07 | Presenter: Miguel Garcia Pardo
- Abstract
Loading...
